Dasatinib Monohydrate2009-10-28
Dasatinib (BMS-354825) is a novel, oral, potent, multi-targeted kinase inhibitor of Bcr-Abl and Src family kinases (SFK) and is a promising cancer therapeutic...
|
Lapatinib Dihydrate2009-10-28
Lapatinib is a promising new breast cancer medication. It is an oral therapy targeting intracellular components of a receptor known as ErbB2 and a second receptor,...
|
Sorafenib Tosylate2009-10-28
Use: Sorafenib is the first oral multi-kinase inhibitor that targets serine/ threonine and receptor tyrosine kinases in both the tumor cell and the tumor...
|
Angoroside C2009-10-28
CAS No.: [115909-22-3]
Molecular Weight: 784.755
Molecular Formula: C 36 H 48O19
Purity: >98%...
|
Sunitinib Malate2009-10-28
Sunitinib (marketed as Sutent, previously known as SU11248) is a small molecule receptor tyrosine kinase inhibitor that is approved for the treatment of...
|
Erlotinib Hcl2009-10-28
Erlotinib is used to treat advanced non-small cell lung cancer (NSCLC), an aggressive type of lung cancer. NSCLC the most common type of lung cancer. It is most...
|
Lenalidomide2009-10-28
Use: Lenalidomide (initially known as CC-5013 and marketed as Revlimid by Celgene) is a derivative of thalidomide introduced in 2004. It was initially intended as a...
|
Celastrol2007-8-31
Appearance: Red cubic crystals
Solubility: Soluble in DMSO, ethanol, and most nonpolar solvents, insoluble in water.
Melting point: 185~200℃ (decomp.)...
|
D-Bicuculline2007-8-31
CAS No.: [485-49-4]
Molecular Weight: 367.35
Molecular Formula: C 20 H 17 N O6
Occurrence: Found in Dicentra cucullaria (L.) Bernh., Adlumia fungosa...
|
Home
Selling Leads